Treatment of Non-small Cell Lung Cancer With Cytokine-induced Killer (CIK) Cells Blocked by PD-1 Antibody
Clinical trial NCT03282435 · UNKNOWN
Trial details
- NCT number
- NCT03282435
- Sponsor
- Dalian University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2023-01-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.